NCT07648901Not yet recruiting
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain Injury
Source: ClinicalTrials.gov · Last updated 16 Jun 2026
Brief summary (registry, in English)
The Investigators have proposed targeted efforts to address the feasibility, effectiveness, fidelity, and evaluation of the GLB-TBI Evidence Based Intervention (EBI) in a real world setting at a CDC-recognized site
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 70 (estimated)
- First submitted
- 10 Jun 2026
- Start date
- 15 Aug 2026
- Primary completion date
- 30 Aug 2028
- Lead sponsor
- Baylor Research Institute
- Diseases
- Obesity
- NCT number
- NCT07648901
What you commit to
- Study type: Observational
- Planned participants: 70
- From 15 Aug 2026 to the primary completion date, 30 Aug 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Pre-existing diagnosis of an eating disorder
Other
- Contraindications to physical activity
- Low cognitive function
- Residing in hospital, acute rehab, SNF
- Self-Reported Pregnancy
- Former DPP-GLB Participants (less than 6months since participation ended)
Who the study is looking for
- 18-80 years of age
- -≥6 months post-TBI
- Moderate to severe TBI at time of injury
- BMI ≥25 kg/m2
- Able to communicate in English
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Baylor Scott & White Research Institute Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.